The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

AMGN FINANCIAL STATEMENTS

Amgen Inc — balance sheet, income statement and cash flow trends

AMGNAmgen Inc

🇺🇸 USA · US · Healthcare · Drug Manufacturers - General

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
020 B40 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue38.1 B $Gross Profit27.7 B $ · 73%Operating Income12.6 B $ · 33%Pre-tax Income10.3 B $ · 27%Net Income to Owners8.7 B $ · 23%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue38.1 B $+9.2%
Gross Profit27.7 B $+23.1%
Operating Income12.6 B $+54.6%
EBITDA16.5 B $+3.8%
Net Income to Owners8.7 B $+32.1%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
050 B100 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets95.6 B
  • Equity11.7 B $12%
  • Current Liabilities25.5 B $27%
  • Long-term Liabilities58.4 B $61%

Key Figures

YoY change
Total Assets95.6 B $+8.8%
Total Liabilities84 B $+4.3%
Total Equity11.7 B $+57.4%
Cash & ST Investments14 B $+74.3%
Total Debt57.3 B $+2.0%
Net Debt43.3 B $-10.1%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
05 B10 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
05 B10 B12.5 B $Operating-2.4 B $Investing-4.1 B $Financing6 B $Net Change

Key Figures

YoY change
Operating Cash Flow12.5 B $+3.9%
Capital Expenditures2.3 B $+63.6%
Free Cash Flow10.2 B $-4.1%
Dividends Paid5.3 B $+6.3%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on AMGN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.